Industry Experts

Dr. Doug Ethell is a distinguished neuroscientist with a robust background in Alzheimer's disease research. He earned his Ph.D. in Neurobiology from the University of British Columbia, Riverside, and has held pivotal roles in both academia and the biotechnology industry. As the Founder and CEO at Leucadia Therapeutics, Dr. Ethell leads innovative efforts to develop treatments aimed at halting Alzheimer's progression. His extensive publication record and numerous patents underscore his commitment to advancing neurodegenerative disease therapies. Dr. Ethell's leadership and scientific acumen continue to drive significant progress in the quest to combat Alzheimer's disease.